Litcius/Paper detail

Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence From a Network Meta-Analysis of Randomized Controlled Trials

Cheng Han Ng, Snow Yunni Lin, Yip Han Chin, Ming Hui Lee, Nicholas Syn, Xin Lei Goh, Jin Hean Koh, Jingxuan Quek, Darren Jun Hao Tan, Shao Feng Mok, Eunice Xiang Xuan Tan, Yock Young Dan, Nicholas Chew, Chin Meng Khoo, Mohammad Shadab Siddiqui, Mark Muthiah

2021Endocrine Practice49 citationsDOI

Topics & Concepts

MedicineNonalcoholic fatty liver diseaseSteatosisInternal medicineType 2 diabetesType 2 Diabetes MellitusRandomized controlled trialMeta-analysisEndocrinologyGastroenterologyDiabetes mellitusFatty liverInsulin resistancePharmacologyInsulinDiseaseLiver Disease Diagnosis and TreatmentDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence From a Network Meta-Analysis of Randomized Controlled Trials | Litcius